Osmol Therapeutics is developing a treatment to prevent CIPN before it starts.
Employees: 1-10
Total raised: $5.2M
Founded date: 2016
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.04.2022 | Series A | $5.2M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 13.04.2022 | Osmol Therapeutics Closes First $5.2M Tranche of $7.5M Serie... | Osmol Therapeutics, a New Haven, Conn.-based biopharmaceutical company focused on developing a treat... | finsmes.co... |